Identification of the first in cis mutations in MYH9 disorder

European Journal of Haematology

Volumn 82, Issue 4, 2009, Pages 288-291

  Miyajima, Yuji ^a   Kunishima, Shinji ^b  

^a ANJO KOSEI HOSPITAL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Alport manifestation; Double mutations; Leukocyte inclusion bodies; MYH9 disorder; Non muscle myosin heavy chain IIA

Indexed keywords

POLYCLONAL ANTIBODY; PROTEIN;

ARTICLE; CASE REPORT; CELL INCLUSION; CHILD; CHROMOSOME DISORDER; CLINICAL FEATURE; FEMALE; FOLLOW UP; GENE IDENTIFICATION; GENE MUTATION; HUMAN; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; LABORATORY TEST; MAY HEGGLIN ANOMALY; MUTATIONAL ANALYSIS; NEUTROPHIL; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN AGGREGATION;

AMINO ACID SEQUENCE; ANIMALS; BLOOD PLATELETS; CHILD, PRESCHOOL; CLONING, MOLECULAR; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; HUMANS; INCLUSION BODIES; MODELS, MOLECULAR; MOLECULAR MOTOR PROTEINS; MUTATION; MYOSIN HEAVY CHAINS; NEUTROPHILS; PROTEIN CONFORMATION; THROMBOCYTOPENIA;

EID: 61349086614     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2008.01202.x     Document Type: Article

References (20)

1. The May-Hegglin/ Fechtner Syndrome Consortium. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. Nat Genet 2000 26 : 103 5.
2. Kelley MJ, Jawien W, Ortel T, Korczak JF. Mutation of MHY9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat Genet 2000 26 : 106 8.
3. Kunishima S, Kojima T, Matsushita T, et al. Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome). Blood 2001 97 : 1147 9.
4. Dong F, Li S, Pujol-Moix N, Luban NC, Shin SW, Seo JH, Ruiz-Saez A, Demeter J, Langdon S, Kelly MJ. Genotype-phenotype correlation in MYH9-related thrombocytopenia. Br J Haematol 2005 130 : 620 7.
5. Kunishima S, Matsushita T, Kojima T, et al. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions. J Hum Genet 2001 46 : 722 9.
6. Arrondel C, Vodovar N, Knebelmann B, Grünfeld JP, Gubler MC, Antignac C, Heidet L. Expression of nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J Am Soc Nephrol 2001 13 : 65 74.
7. Heath KE, Campos-Barros A, Toren A, et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndrome. Am J Hum Genet 2001 69 : 1033 45.
8. Seri M, Pecci A, DiBari F, et al. MYH9- related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine 2003 82 : 203 15.
9. Saito H, Matsushita T, Yamamoto T, Kojima T, Kunishima S. Giant platelet syndrome. Hematology 2005 10 : 41 6.
10. Kunishima S, Saito H. Congenital macrothrombocytopenias. Blood Rev 2006 20 : 111 21.
11. Pecci A, Panza E, Pujol-Moix N, et al. Position on nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease. Hum Mutat 2008 29 : 409 17.
12. Kunishima S, Yoshinari M, Nishio H, Ida K, Miura T, Matsusita T, Hamaguchi M, Saito H. Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations. Eur J Hematol 2007 78 : 220 6.
13. Kunishima S, Matsushita T, Kojima T, Sako M, Kimura F, Jo EK, Inoue C, Kamiya T, Saito H. Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain- A in MYH9 disorders: association of subcellular localization with MYH9 mutations. Lab Invest 2003 83 : 115 22.
14. Sellers JR. Myosins: a diverse superfamily. Biochim Biophys Acta 2000 1496 : 3 22.
15. Ma ES, Wong CL, Shek TW, Hui SP. Hematological and genetic characterization of an MYH9-related disorder in a Chinese family. Haematologica 2006 91 : 1002 3.
16. Kunishima S, Matsushita T, Shiratsuchi T, Ikuta T, Nishimura J, Hamaguchi M, Naoe T, Saito H. Detection of unique neutrophil non-muscle myosin heavy chain-A localization by immunofluorescence analysis in MYH9 disorder presented with macrothrombocytopenia without leukocyte inclusions and deafness. Eur J Haematol 2005 74 : 1 5.
17. Saposnik B, Binard S, Elbaz S, et al. Identification of 8 novel mutation in the non-muscle myosin heavy chain 9 (MYH9) gene in 11 unrelated patients with macrothrombocytopenia. J Thromb Haematol 2007 5 (Suppl. 2 PT223.
18. Capria M, Andreucci M, Fuiano L, Mancuso D, Cianfrone P, Comi N, Mazza G, Caglioti A, Fuiano G. Double nucleotidic mutation of the MYH9 gene in a young patient with end-stage renal disease. Nephrol Dial Transplant 2004 19 : 249 51.
19. Kunishima S, Hamaguchi M, Saito H. Differential expression of wild-type and mutant NMMHC-IIA polypeptides in blood cells suggests cell-specific regulation mechanisms in MYH9 disorders. Blood 2008 111 : 3015 23.
20. Drachman JG. Inherited thrombocytopenia: when a low platelet count does not mean ITP. Blood 2004 103 : 390 8.